{"id":"https://openalex.org/W51644250","doi":null,"title":"Leflunomide Aventis Pharma.","display_name":"Leflunomide Aventis Pharma.","publication_year":2001,"publication_date":"2001-02-01","ids":{"openalex":"https://openalex.org/W51644250","mag":"51644250","pmid":"https://pubmed.ncbi.nlm.nih.gov/11816835"},"language":"en","primary_location":{"id":"pmid:11816835","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11816835","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"M J Kaplan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"M J Kaplan","raw_affiliation_strings":["University of Michigan Medical Center, Division of Rheumatology, Ann Arbor 48109-1065, USA. makaplan@umich.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Medical Center, Division of Rheumatology, Ann Arbor 48109-1065, USA. makaplan@umich.edu","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"],"apc_list":null,"apc_paid":null,"fwci":0.4202,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.60570574,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"2","issue":"2","first_page":"222","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/leflunomide","display_name":"leflunomide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.8289999961853027},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.4189999997615814},{"id":"https://openalex.org/keywords/disease-modifying-antirheumatic-drugs","display_name":"disease-modifying antirheumatic drugs","score":0.8859999775886536},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.8980000019073486},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.5950000286102295},{"id":"https://openalex.org/keywords/drug-launch","display_name":"drug launch","score":0.4959999918937683},{"id":"https://openalex.org/keywords/transplant-rejection-prevention","display_name":"transplant rejection prevention","score":0.6949999928474426},{"id":"https://openalex.org/keywords/pregnancy-contraindication","display_name":"pregnancy contraindication","score":0.7889999747276306},{"id":"https://openalex.org/keywords/teratogenicity","display_name":"teratogenicity","score":0.8510000109672546},{"id":"https://openalex.org/keywords/experimental-autoimmune-encephalomyelitis","display_name":"experimental autoimmune encephalomyelitis","score":0.8690000176429749},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9430000185966492},{"id":"https://openalex.org/keywords/pancytopenia","display_name":"pancytopenia","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C2775905006","wikidata":"https://www.wikidata.org/wiki/Q248550","display_name":"Leflunomide","level":3,"score":0.9904174208641052},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8326608538627625},{"id":"https://openalex.org/C2777703276","wikidata":"https://www.wikidata.org/wiki/Q3077133","display_name":"Teriflunomide","level":4,"score":0.7041946649551392},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.6013885140419006},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44757041335105896},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27627694606781006},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22303277254104614},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.10407319664955139},{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000075202","descriptor_name":"Contraindications","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077339","descriptor_name":"Leflunomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11816835","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11816835","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},{"id":"mag:51644250","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11816835","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.979200005531311}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4231148605","https://openalex.org/W1969340572","https://openalex.org/W4298443248","https://openalex.org/W2075140103","https://openalex.org/W2036813676","https://openalex.org/W274610211","https://openalex.org/W2417732172","https://openalex.org/W2621651773","https://openalex.org/W2740507306","https://openalex.org/W2054218135"],"abstract_inverted_index":{"Hoechst":[0],"Marion":[1],"Roussel":[2],"(HMR;":[3],"now":[4],"Aventis":[5],"Pharma)":[6],"launched":[7,39,95],"leflunomide":[8,83,130,162,189,220,253],"(HWA-486),":[9],"an":[10,210,264],"immunomodulator":[11],"and":[12,46,92,123,166,268],"a":[13,168,185,223,270],"disease-modifying":[14],"antirheumatic":[15],"drug":[16,181],"(DMARD),":[17],"for":[18,71,84,113,126,196],"the":[19,26,35,60,80,85,104,108,111,127,155,180],"treatment":[20,86],"of":[21,43,62,87,110,129,179,213,258,275],"rheumatoid":[22],"arthritis":[23],"(RA)":[24],"in":[25,28,47,74,90,118,131,133,190,209,230,241,273],"US":[27,276],"late":[29],"1998":[30,197],"[310118].":[31,100],"By":[32],"August":[33,153],"2000,":[34],"compound":[36,54],"had":[37,184],"been":[38,203],"extensively":[40],"across":[41],"all":[42,48],"Latin":[44],"America":[45],"major":[49],"European":[50],"countries":[51],"[380046].":[52],"The":[53],"is":[55,238],"also":[56],"under":[57],"preclinical":[58],"investigationfor":[59],"prevention":[61],"transplant":[63],"rejection":[64],"[279727],":[65],"[304402].":[66],"In":[67,77,101,152,251],"1998,":[68,79,154],"HMR":[69],"filed":[70],"approvalfor":[72],"RA":[73,89,132],"Europe":[75],"[279727].":[76],"September":[78,102],"FDA":[81],"approved":[82],"active":[88,245],"adults":[91,134],"it":[93],"was":[94,143,194,254],"shortly":[96],"thereafter":[97],"[298204],":[98],"[299258],":[99],"1999,":[103],"EU":[105,141],"Commission":[106],"accepted":[107],"view":[109],"Committee":[112,158],"Proprietary":[114],"Medicinal":[115],"Products,":[116],"published":[117],"May":[119],"1999":[120],"[326040],":[121],"[337534],":[122],"gave":[124],"approval":[125,193],"use":[128],"[339128].":[135],"Lehman":[136],"Brothers":[137],"has":[138,202],"reported":[139,204],"that":[140,161,167],"launch":[142],"delayed":[144],"by":[145],"rare":[146],"side":[147],"effects":[148,178],"including":[149],"pancytopenia":[150],"[354434].":[151],"Arthritis":[156],"Advisory":[157],"unanimously":[159],"recommended":[160],"be":[163,172,222],"contraindicatedfor":[164],"pregnancy,":[165],"pregnancy":[169],"registry":[170],"should":[171],"established":[173],"to":[174,187,221,243],"monitor":[175],"possible":[176],"teratogenic":[177],"[296187].":[182],"Kyorin":[183],"licence":[186],"develop":[188],"Japan.":[191],"Product":[192],"scheduled":[195],"[159079],":[198],"but":[199],"no":[200],"development":[201],"since":[205],"1994.":[206],"Preclinical":[207],"studies":[208],"animal":[211],"model":[212],"experimental":[214],"allergic":[215],"encephalomyelitis":[216],"(EAE)":[217],"have":[218,228],"shown":[219],"powerful":[224],"immunosuppressant":[225],"which":[226],"may":[227],"potential":[229,271],"diseases":[231],"such":[232],"as":[233,256],"multiple":[234],"sclerosis":[235],"[187881].":[236],"Leflunomide":[237],"rapidly":[239],"processed":[240],"vivo":[242],"its":[244],"metabolite,":[246],"A-771726":[247],"(RS-61980)":[248],"[202941],":[249],"[253615].":[250],"1996,":[252],"designated":[255],"one":[257],"HMR's":[259],"nine":[260],"top-priority":[261],"products,":[262],"serving":[263],"unmet":[265],"medical":[266],"need":[267],"addressing":[269],"market":[272],"excess":[274],"$500":[277],"million":[278],"per":[279],"year":[280],"[221118].":[281]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}